Jundishapur Journal of Microbiology
Scope & Guideline
Exploring the frontiers of infectious disease research.
Introduction
Aims and Scopes
- Microbiological Pathogenesis and Disease:
Research focusing on the role of various microorganisms in human diseases, including bacterial, viral, and fungal infections. Studies often explore the mechanisms of pathogenicity and host-pathogen interactions. - Antimicrobial Resistance:
A significant emphasis on the emergence and mechanisms of resistance in pathogens, particularly focusing on multidrug-resistant strains and the genetic basis of resistance mechanisms. - Clinical Microbiology and Infectious Diseases:
Investigations into clinical cases, epidemiological studies, and the characterization of microbial infections in different populations, including children and immunocompromised patients. - Diagnostic Innovations:
Development and evaluation of new diagnostic methods, including molecular techniques, to improve the identification and management of infectious diseases. - Environmental Microbiology:
Research on the microbial diversity in various environments, including clinical settings, and the impact of microorganisms on public health. - Therapeutic Approaches:
Exploration of new therapeutic agents, including the use of phages, probiotics, and novel compounds to combat infections and improve treatment outcomes.
Trending and Emerging
- COVID-19 Related Research:
A significant increase in studies related to COVID-19, including its clinical impacts, associated infections, and immune responses. This trend highlights the ongoing global health crisis and its implications for microbiology. - Molecular Characterization and Genomics:
Emerging focus on the genomic characterization of pathogens to understand their resistance mechanisms and virulence factors, reflecting advancements in sequencing technologies. - Biomarkers for Disease Severity:
Growing interest in identifying biomarkers associated with the severity of infectious diseases, particularly for COVID-19 and other viral infections, which can aid in prognosis and treatment. - Therapeutic Drug Monitoring and Personalized Medicine:
Increasing research on therapeutic drug monitoring, particularly in pediatric and immunocompromised populations, indicating a trend towards personalized treatment strategies. - Novel Antimicrobial Strategies:
Emerging studies on innovative therapeutic approaches, including the use of phage therapy, antimicrobial peptides, and natural products, to combat resistant strains.
Declining or Waning
- Traditional Antibiotic Studies:
There has been a noticeable reduction in studies focused solely on traditional antibiotics without exploring multidrug resistance or novel therapeutic approaches. This shift indicates a growing awareness of the limitations of existing antibiotics. - Non-Clinical Microbiology:
Research that previously focused on non-clinical settings, such as environmental or industrial microbiology, is less frequently reported, suggesting a shift towards clinical applications and human health. - Basic Microbial Ecology:
Basic studies on microbial ecology and diversity without direct clinical relevance have decreased, possibly due to increased emphasis on translational research that directly impacts patient care.
Similar Journals
ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA
Shaping the future of microbiological inquiry.ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA is a distinguished academic journal published by AKADEMIAI KIADO ZRT, focusing on significant advancements in the fields of microbiology, immunology, and infectious diseases. Established in 1994, this journal serves as a vital platform for researchers, professionals, and students keen on exploring the complexities of microbial interactions and immune responses. With a current Impact Factor reflecting its rank within the Q3 categories for Immunology, Microbiology, and Infectious Diseases, it retains a critical position in disseminating innovative research. Although not open access, the journal provides extensive insights disseminated through various academic databases, ensuring a broad reach within the scholarly community. Its convergence over three decades indicates a robust commitment to excellence in scientific inquiry and knowledge sharing. As it moves towards the future, ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA continues to uphold its legacy of fostering collaborative research initiatives that contribute to the understanding and treatment of microbial diseases globally.
Mediterranean Journal of Infection Microbes and Antimicrobials
Innovating solutions for a healthier tomorrow.Mediterranean Journal of Infection Microbes and Antimicrobials is a distinguished open-access journal published by GALENOS PUBL HOUSE, dedicated to advancing the understanding of infectious diseases and microbiology. Since its inception in 2011, this journal has been a vital resource for researchers, professionals, and students interested in the intricate world of microbes and their impacts on human health. With its ISSN 2147-673X, the journal has progressively gained visibility, although it currently holds a Q4 ranking in multiple categories including Immunology and Microbiology, and Infectious Diseases for the year 2023. The journal operates from its headquarters in Istanbul, Turkey, and features a rich array of articles that contribute to the field’s body of knowledge. As a platform enhancing the accessibility of research, it invites submissions from global contributors to foster collaboration and innovation in tackling microbial challenges.
Reviews and Research in Medical Microbiology
Advancing the Frontiers of Medical MicrobiologyReviews and Research in Medical Microbiology is a premier academic journal published by LIPPINCOTT WILLIAMS & WILKINS, focusing on groundbreaking research and comprehensive reviews that advance the understanding of medical microbiology. With an ISSN of 2770-3150 and an E-ISSN of 2770-3169, this journal serves as an essential resource for researchers, healthcare professionals, and students dedicated to the study of pathogens, infectious diseases, and microbial mechanisms affecting health. While the journal currently does not offer open access, its rigorous peer-review process ensures that only high-quality, impactful research is disseminated to the scientific community. The journal aims to bridge gaps in knowledge by presenting cutting-edge studies that explore novel therapeutic strategies, diagnostic methods, and the evolving landscape of microbial resistance. Nestled in the heart of Philadelphia, this journal proudly contributes to the advancement of medical microbiology and is an indispensable platform for the publication of critical findings that shape clinical practices and research trajectories in the field.
Microbiology Research
Exploring the Microbial Universe, One Study at a TimeMicrobiology Research, published by MDPI, stands as a pivotal open-access journal in the field of microbiology, having established its presence since 2010. Based in Switzerland, this journal strives to provide a platform for innovative research and cutting-edge findings in various branches of microbiology, including medical microbiology and molecular biology. With an impact factor that reflects its dedication to scholarly excellence, Microbiology Research is classified in the Q3 category for both microbiology and medical microbiology, and Q4 for molecular biology as of 2023, indicating its growing importance and outreach within these domains. The journal aims to foster discussion and collaboration among researchers, professionals, and students by presenting articles that cover a wide array of topics and methodologies in microbiological research. Leveraging its open-access model, Microbiology Research ensures that high-quality research is accessible to a global audience, thus facilitating the advancement of knowledge and innovation in the microbial sciences.
MicrobiologyOpen
Advancing microbiological research for a global audience.MicrobiologyOpen is a prestigious, open access journal published by WILEY, dedicated to advancing the field of microbiology. Since its inception in 2012, this journal has firmly established itself as a significant platform for researchers, professionals, and students alike, facilitating the dissemination of high-quality research findings across a wide range of microbiological disciplines. With an impressive impact factor and a ranking in the 76th percentile of Scopus for immunology and microbiology, MicrobiologyOpen offers a robust forum for innovative studies, reviews, and compelling insights that push the boundaries of scientific understanding. The journal's commitment to open access ensures that groundbreaking research is freely available to the global community, fostering collaboration and knowledge-sharing. As it continues to evolve until 2024, MicrobiologyOpen remains pivotal for anyone looking to stay at the forefront of microbiological research.
FEMS MICROBIOLOGY REVIEWS
Elevating the Standards of Microbiological ReviewFEMS Microbiology Reviews, published by Oxford University Press, is a leading journal in the field of microbiology, with a notable impact in related disciplines such as infectious diseases and medicine. Since its inception in 1989, this esteemed journal has grown to occupy a prestigious position, consistently ranking in the first quartile (Q1) in various categories, including Infectious Diseases, Medicine (miscellaneous), and Microbiology. With an impressive Scopus ranking of #13 in Microbiology and #25 in Infectious Diseases, it is recognized for its high-quality and impactful reviews that bridge the gap between fundamental microbiological research and practical applications. Aimed at researchers, professionals, and students alike, FEMS Microbiology Reviews offers critical insights and comprehensive analyses, making it an essential resource for those engaged in the dynamic study of microbial life and its implications for health and disease.
Frontiers in Cellular and Infection Microbiology
Unlocking the secrets of immunity and infectious diseases.Frontiers in Cellular and Infection Microbiology, published by FRONTIERS MEDIA SA, is a leading Open Access journal that has been at the forefront of microbiological research since 2011. Located in Switzerland, this journal aims to provide a platform for innovative and impactful studies in various domains including immunology, infectious diseases, and medical microbiology. With an impressive range of quartile rankings—Q1 in Infectious Diseases, Microbiology, and Microbiology (medical), and Q2 in Immunology—as of 2023, it positions itself as a highly reputable source in the academic community. Furthermore, its Scopus rankings highlight its significance within the respective fields, with top percentiles in key categories, making it an essential resource for researchers, professionals, and students alike. As an Open Access publication, it ensures that vital findings are accessible to a global audience, fostering collaboration and advancement in science.
REVISTA ARGENTINA DE MICROBIOLOGIA
Connecting experts to foster innovative microbiological insights.REVISTA ARGENTINA DE MICROBIOLOGIA, published by the ASOCIACION ARGENTINA MICROBIOLOGIA, stands as a prominent open-access journal in the field of microbiology and medicine since its establishment in 1979. With an ISSN of 0325-7541 and an E-ISSN of 1851-7617, this journal has paved the way for disseminating high-quality research while enhancing accessibility for academics and practitioners worldwide. The journal has achieved notable rankings, being classified in Q3 for Medicine (miscellaneous) and Q3 for Medical Microbiology in 2023, reflecting its commitment to advancing knowledge in these critical areas. Despite its relatively modest impact factors, it occupies a vital niche in the academic landscape, fostering collaborations and innovative research among experts. With Open Access available since 2013, REVISTA ARGENTINA DE MICROBIOLOGIA not only facilitates widespread distribution of valuable scientific information but also empowers researchers, professionals, and students to stay abreast of the latest findings and developments in microbiology. For those engaged in the evolving realm of microbiology, this journal serves as an essential resource for sharing insights and advancing the scientific community.
MIKROBIYOLOJI BULTENI
Exploring Innovations in Infectious Disease ResearchMIKROBIYOLOJI BULTENI, with ISSN 0374-9096, is a prestigious academic journal published by the ANKARA MICROBIOLOGY SOC, located in Ankara, Turkey. Established in 1973, this journal has been a vital conduit for disseminating research in the fields of Immunology, Microbiology, and Infectious Diseases, garnering a reputation as a significant contributor to the scientific community. The journal is currently ranked in the Q3 category within Immunology and Microbiology (miscellaneous), and Infectious Diseases, indicating its impactful presence amidst contemporary research. With access options that may be restricted, MIKROBIYOLOJI BULTENI actively welcomes submissions that advance the understanding of critical microbiological principles and practices, thereby supporting both national and international research efforts. Researchers, professionals, and students are encouraged to explore the latest findings shared in this journal, as it continually shapes the landscape of microbiology and infectious disease studies through its comprehensive and rigorous peer-reviewed publications.
Indian Journal of Medical Microbiology
Bridging Science and Clinical Practice in MicrobiologyIndian Journal of Medical Microbiology, published by Elsevier, is a pivotal peer-reviewed journal dedicated to the field of medical microbiology, providing a vital platform for research and scholarship since its inception in 1986. With an Open Access model established in 2001, it ensures the dissemination of scientific knowledge to a global audience, enhancing accessibility for researchers, professionals, and students alike. The journal's scope spans critical areas including immunology, infectious diseases, and microbiology, with an impressive trajectory marked by converged years of publication allowing for a comprehensive exploration of evolving scientific trends. As of 2023, the journal holds a Q3 ranking in Infectious Diseases and Microbiology (medical) and a Q4 ranking in Immunology and Microbiology categories, reflecting its significant yet growing impact in the field. Researchers seeking to contribute to or stay updated on the latest advancements in medical microbiology will find the Indian Journal of Medical Microbiology a valuable resource, as it consistently bridges the gap between emerging science and clinical application.